Sign in to follow
Search Results

0 results for 'BristolMyers Squibb'

You can use to get even better search results
June 12, 2024 | The Legal Intelligencer

Bristol-Myers Squibb, Cencora Face Data Breach Class Action

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
February 05, 2024 | National Law Journal

Arguing Class Actions: Who Has Home-Field Advantage Post Bristol-Myers Squibb?

Arguing Class Actions is a monthly column for the National Law Journal written by DiCello Levitt's Adam J. Levitt.
8 minute read
October 20, 2023 | Daily Report Online

The Proper and Practical Application of Bristol-Myers Squibb to Class Actions

The U.S. Supreme Court case Bristol-Myers Squibb Co. v. Superior Court of California was specific to state courts and the Fourteenth Amendment, but it presents a broader, federal issue regarding class actions.
7 minute read
May 01, 2023 | Delaware Business Court Insider

AstraZeneca Alleges Bristol-Myers Squibb's Cancer Treatment Infringes on Antibody Patent

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
October 18, 2022 | New Jersey Law Journal

Bristol-Myers Squibb Taps Morgan Lewis in Employee Class Action Over COVID-19 Vaccination Policy

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
Law Journal Press | Digital Book New York Employment Law 2023 Authors: Daniel A. Cohen, Joshua Feinstein View this Book

View more book results for the query "BristolMyers Squibb"

October 03, 2022 | New Jersey Law Journal

Bristol-Myers Squibb Facing Suit From Workers Fired for Refusing COVID Vaccine

"According to Bristol-Myers Squibb, people who worked on their computers all day remotely during the pandemic couldn't be accommodated. They didn't try," plaintiffs lawyer John Coyle said.
4 minute read
August 30, 2022 | New Jersey Law Journal

Bristol-Myers Squibb Facing Suit Over Termination Based on Vaccine Status

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
March 11, 2022 | New York Law Journal

2nd Circuit Upholds Dismissal of Securities Suit Targeting Bristol-Myers Squibb Over Failed Trial

The panel upheld a lower court's dismissal of a proposed securities class action, which claimed that Bristol-Myers Squibb made material misstatements or omissions around a clinical trial to determine the drug's efficacy for treating certain kinds of lung cancers.
3 minute read
December 13, 2021 | New Jersey Law Journal

Bristol-Myers Squibb, Celgene Face Antitrust Suit Over Cancer Drugs

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
October 15, 2021 | New Jersey Law Journal

Patent Infringement Suit Against Bristol-Myers, Celgene Targets Multiple Sclerosis Treatment

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now

  • Retention & Online Reputation for Law Firms: 2025 Guide

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • Europe's Escalating Regulatory Framework: Mapping Efforts to Mitigate Supply Chain Risks

    Brought to you by LRN

    Download Now